Companies / Actuate Therapeutics, Inc.

Actuate Therapeutics, Inc.

Nasdaq: ACTUCIK 1652935FORT WORTH, TX

Financials

Revenue
Net income$-22.23M
Total debt
Cash$8.13M
Diluted EPS$-1.06
Shares outstanding23.9M

Ownership

23.9M shares outstanding · as of May 13, 2026
4.4%Insiders
Ownership
Insiders4.41%1,054,976
Institutions53.48%12,796,683
Public float42.11%10,074,193

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Thomson Todd SDirector · 10% owner
3.78%904,795
Schmitt Daniel MCEOPresident, CEO and Director · Director
0.63%150,181
Lytle Paul JChief Financial Officer

Institutional holders 48

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 5, 2026Thomson Todd S
Director
SellCommon Stock$1.62M-280K
-23.63%
904,795
3.78% of shares
medium
Feb 13, 2026Schmitt Daniel M
CEO
OtherCommon Stock$527.7K-122K
-44.80%
150,181
0.63% of shares
low
Feb 13, 2026Schmitt Daniel M
CEO
ExerciseCommon Stock$0+272K
272,055
1.14% of shares
low
May 21, 2026Ronneberg Amy L
Director
GrantStock Options+15K
15,000
0.06% of shares
low
Apr 1, 2026Schmitt Daniel M
CEO
GrantEmployee Stock Option (right to buy)+237K
237,000
0.99% of shares
low
Apr 1, 2026Lytle Paul J
Executive
GrantEmployee Stock Option (right to buy)+105K
105,000
0.44% of shares
low
May 21, 2026Thomson Todd S
Director
GrantStock Options+15K
15,000
0.06% of shares
low
Feb 13, 2026Schmitt Daniel M
CEO
ExerciseRestricted Stock Units-272K
-50.00%
272,056
1.14% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ACTUCommon StockEquity005083100BBG00NK7LK03